AUSTIN, Texas, Feb. 22, 2022 (Globe NEWSWIRE) — Aspira Girls’s Properly being, Inc. (Nasdaq: AWH), a bioanalytical-based ladies’s nicely being agency, these days launched the appointment of Mr. Michael Newton as Head of Gross sales and Promoting and advertising and marketing who brings to the company greater than 20 a very long time of expertise within the diagnostic healthcare spot.
On this operate, Mr. Newton might be accountable for overseeing the Firm’s complete U.S. commercialization technique, which embody current items, new gadgets and future services. He’ll lead the nationwide gross sales drive, driving adoption of the OVA1Plus merchandise and creating it as the conventional of take care of early hazard detection of ovarian most cancers, serving to to realize the aim of growing Aspira as an enterprise chief in gynecologic total well being.
“We’re enthusiastic to welcome Michael to the Aspira family members. He delivers a prosperity of data within the commercialization of diagnostics collectively together with his strategic and tactical arranging strategies and information in driving earnings and advertising and marketing companies. He’ll unquestionably be instrumental in utilizing the Firm to the following diploma of improvement and market adoption of our floor breaking options,” said Valerie Palmieri, President and CEO of Aspira. “We look forward to his contributions in driving consciousness, growth and basically product adoption.”
Mr. Newton further, “I’m thrilled to be part of this enthusiastic workers to ascertain Aspira as a pacesetter in ladies’s gynecological well being and health. The workforce under has carried out an exceptional job elevating recognition, and I appear forward to having it to the longer term quantity.”
Mr. Michael J. Newton joins Aspira from his function as Major Enterprise Officer at Perception Well being-related Genetics, a complete-assistance genetic testing enterprise targeting ladies’s nicely being, wherein he led earnings, selling, schooling, and earnings operations. Previous to that, he was the Major Operating Officer at Legion Victrix Corp, and led earnings and selling at Defend Bio. Mr. Newton rose by means of the gross sales ranks at Roche Sequencing, the place he served as regional enterprise enterprise director promoting and advertising and marketing the Concord NIPT Check out, a genetic sequencing examination for prenatal abnormalities. He commenced his vocation at Valeant Dermatology the place by he was the best-ranked earnings director 4 a long time jogging. Mr. Newton holds a Bachelor of Typical Experiments with minors in psychology, sociology, and English from the Louisiana Level out School
About Aspira Girls’s Properly being Inc.
Aspira Girls’s Well being Inc. is remodeling ladies’s wellbeing with the invention, enchancment, and commercialization of progressive screening prospects and bio-analytical options that help physicians consider risk, enhance shopper administration, and enhance gynecologic total well being outcomes for women. Aspira Girls’s Wellness is particularly targeted on closing the ethnic disparity gap in ovarian most cancers danger evaluation and growing options for pelvic illnesses comparable to pelvic mass risk analysis and endometriosis. OVA1as nicely asTM brings collectively our Meals and drug administration-cleared gadgets, OVA1® and OVERA®, to detect hazard of ovarian malignancy in ladies with adnexal plenty. Aspira GenetiXTM testing options each equally targeted and detailed genetic screening options with a gynecologic goal. With above 10 years of know-how in ovarian most cancers probability analysis, Aspira Girls’s Well being is functioning to produce a portfolio of pelvic mass merchandise above a affected person’s life span with our slicing-edge examine. The long run period of options in enchancment comprise OVAWatchTM and EndoCheckTM. To strengthen particular person accessibility, Aspira Girls’s Wellness has not way back launched our Aspira Synergy applied sciences switch platform to empower wellness strategies, lecturers, regional labs, and medical physician workforce labs to conduct genetic and specialty assessments in-dwelling. Go to our web site for extra data and info at www.aspirawh.com.
This press launch consists of forward-seeking statements, as described within the Private Securities Litigation Reform Act of 1995, like statements pertaining to the expected use of Aspira Synergy Genetics by Axia Girls’s General well being medical professionals and the anticipated begin of Aspira Synergy specialty exams. These statements comprise a variety of risks and uncertainties. All statements apart from statements of historic particulars contained on this push launch are ahead-wanting statements. Phrases and phrases these as “could,” “expects,” “intends,” “anticipates,” “believes,” “estimates,” “plans,” “seeks,” “might,” “ought to,” “proceed,” “will,” “potential,” “initiatives” and really related expressions are supposed to find ahead-hunting statements. These ahead-on the lookout statements speak solely as of the date of this press launch and are matter to various challenges, uncertainties, and assumptions, such because the challenges and uncertainties defined within the section entitled “Threat Elements” in Aspira Girls’s Well being’s Annual Report on Sort 10-Ok for the yr completed December 31, 2020. The gatherings and scenario mirrored in Aspira Girls’s Well being’s ahead-looking statements could presumably not be reached or happen and precise advantages might differ materially from people projected within the forward-searching statements. Aspira Girls’s Wellbeing expressly disclaims any obligation to replace, amend or clarify any forward-wanting statements to replicate capabilities, new knowledge or cases transpiring simply after the day of this push launch, besides as wanted by regulation.
Investor Relations Pay money for:
Ashley R. Robinson
LifeSci Advisors, LLC